Wellgistics director exercises 100K share warrants
Wellgistics Health director Surendra K. Ajjarapu exercised warrants to acquire 100,000 shares of Common Stock at $0.005 per share on June 22, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Wellgistics Health director Surendra K. Ajjarapu exercised warrants to acquire 100,000 shares of Common Stock at $0.005 per share on June 22, 2026. The warrants had been issued on March 31, 2026 in lieu of cash compensation. Following the issuer’s reverse stock split effective May 26, 2026 and this warrant conversion, Ajjarapu directly holds 257,645 shares of Common Stock, and the exercised warrant position is reduced to zero.
Insider Trade Summary
100,000 shares exercised/converted
Exercise
2 txns
Insider
AJJARAPU SURENDRA K
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Warrant | 100,000 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 100,000 | $0.005 | $500.00 |
Holdings After Transaction:
Warrant — 0 contracts (Direct);
Common Stock — 257,645 shares (Direct)
Footnotes (2)
- F1. Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person.
- F2. Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants.
Key Figures
Shares acquired via exercise: 100,000 shares
Exercise price: $0.005 per share
Post-transaction holdings: 257,645 shares
+2 more
5 metrics
Shares acquired via exercise
100,000 shares
Common Stock acquired on June 22, 2026 through warrant exercise
Exercise price
$0.005 per share
Conversion or exercise price for warrants into Common Stock
Post-transaction holdings
257,645 shares
Common Stock directly held after reverse split and warrant conversion
Warrants exercised
100,000 warrants
Derivative position in Warrants converted into Common Stock
Warrant expiration
March 31, 2031
Original expiration date of exercised warrants
Key Terms
Exercise of in-the-money or at-the-money derivative security, Warrants, in lieu of cash compensation, reverse stock split, +1 more
5 terms
Exercise of in-the-money or at-the-money derivative security financial
"transaction_code_description: Exercise of in-the-money or at-the-money derivative security"
Warrants financial
"Represents the conversion of warrants (the "Warrants") issued to the Reporting Person"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
in lieu of cash compensation financial
"Warrants issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due"
reverse stock split financial
"Reflects the aggregate amount of Common Stock held following the Issuer's reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Common Stock financial
"Reflects the aggregate amount of Common Stock held by the Reporting Person"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Wellgistics Health (WGRX) report in this Form 4?
Wellgistics Health reported that director Surendra K. Ajjarapu exercised warrants to acquire 100,000 shares of Common Stock at $0.005 per share. The transaction converted derivative warrants into direct share ownership without any reported open-market buying or selling activity.
What were the key terms of the warrants exercised in the Wellgistics Health (WGRX) Form 4?
The warrants allowed acquisition of 100,000 shares of Wellgistics Health Common Stock at a conversion or exercise price of $0.005 per share. They were originally issued to Surendra K. Ajjarapu on March 31, 2026 in lieu of cash compensation owed to him.
Did the Wellgistics Health (WGRX) insider Form 4 report any open-market stock sales or purchases?
The Form 4 shows no open-market purchases or sales. Instead, it reports an in-the-money exercise of derivative warrants into 100,000 Common Stock shares, with the warrants going to zero and the director’s direct share holdings increasing accordingly.
How did Wellgistics Health’s (WGRX) reverse stock split affect the insider’s reported holdings?
The reported 257,645 Common Stock shares held by Surendra K. Ajjarapu already incorporate the effects of Wellgistics Health’s reverse stock split effective May 26, 2026, as well as the additional shares issued through the conversion of his warrants.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates